EUVIMEDEUVIMED entdecken
Crossref

NBDP ameliorates metabolic-associated steatohepatitis by suppressing IL-17/STAT3 signaling and caspase-mediated apoptosis

Ningning Zhou, Zejun Qi, Kailiang Zhou, Jianjun Qi

Cellular Signalling · 2027-01 · 149 · 112944

DOI: 10.1016/j.cellsig.2026.112944 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2027-01. Verfasst von Ningning Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, 310015, China. Die Arbeit nennt 79 Literaturangaben. Gefördert von: Department of Education of Anhui Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatohepatitis (MASH) is driven by metabolic dysregulation, and progresses from simple steatosis to hepatocyte injury, inflammation, and fibrosis, making it a growing global health burden. MASH research has progressed rapidly in recent years, but effective therapeutic options remain limited. New agents with strong clinical efficacy are urgently needed. The NEMO-binding domain peptide (NBDP) is known to inhibit NF-κB activation and attenuate fibrosis in vivo. However, NBDP has not been studied in MASH. In this study, we employed a diet-induced MASH mouse model and an in vitro co-culture system to evaluate the therapeutic efficacy and underlying mechanisms of NBDP. Network pharmacology identified signal transducer and activator of transcription 3 (STAT3) as a key target of NBDP. Single-cell virtual knockout analysis further indicated that STAT3 overexpression closely mimics MASH progression. Histological and Western blot analyses showed that NBDP significantly restored hepatic architecture, as evidenced by marked reductions in lipid accumulation, inflammatory infiltration, extracellular matrix deposition, and hepatocyte apoptosis. Mechanistically, using STAT3-overexpressing MASH mice and a STAT3-knockdown/IL-17-stimulated in vitro co-culture system, we found that NBDP suppresses the IL-17/STAT3 signaling axis. This inhibition reduces fibrogenesis and caspase-dependent apoptosis during MASH progression. These findings suggest that NBDP ameliorates the main pathological features of MASH by targeting the IL-17/STAT3 pathway. Collectively, this study provides mechanistic insights and experimental validation for NBDP as a potential therapeutic strategy against MASH.

Schlagwörter

Stichwörter der Autor:innen

Caspase-dependent apoptosisExtracellular matrix remodelingIL-17MASHSTAT3 activation

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, 310015, China.
  • School of Nursing, Wannan Medical University, Wuhu, 241002, China.
  • Department of Orthopaedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325027, China; Zhejiang Provincial Key Laboratory of Orthopaedics, Wenzhou, 325027, China…
  • Department of Laboratory Medicine, The First Affiliated Hospital of Wannan Medical University (Yijishan Hospital of Wannan Medical University), Wuhu, 241001, China; Zhejiang Provincial Key Laboratory of Orthopaedics, We…

Förderung

  • Department of Education of Anhui Province

Zitieren

APA

Zhou, N., Qi, Z., Zhou, K., & Qi, J. (2027). NBDP ameliorates metabolic-associated steatohepatitis by suppressing IL-17/STAT3 signaling and caspase-mediated apoptosis. Cellular Signalling, 149, 112944. https://doi.org/10.1016/j.cellsig.2026.112944

Vancouver

Zhou N, Qi Z, Zhou K, Qi J. NBDP ameliorates metabolic-associated steatohepatitis by suppressing IL-17/STAT3 signaling and caspase-mediated apoptosis. Cellular Signalling. 2027;149:112944. doi:10.1016/j.cellsig.2026.112944

BibTeX
@article{Zhou2027,
  author = {Zhou, Ningning and Qi, Zejun and Zhou, Kailiang and Qi, Jianjun},
  title = {NBDP ameliorates metabolic-associated steatohepatitis by suppressing IL-17/STAT3 signaling and caspase-mediated apoptosis},
  journal = {Cellular Signalling},
  year = {2027},
  volume = {149},
  pages = {112944},
  doi = {10.1016/j.cellsig.2026.112944}
}
Kostenlos starten →